| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Cutting Edge |
Department of Biochemistry, University of Texas Health Science Center, Tyler, TX, 75708
Incidents of hemolytic uremic syndrome (HUS) include a subset of patients that exhibit mutations in C factor H. These mutations cluster in the C-terminal domains of factor H where previous reports have identified polyanion and C3b-binding sites. In this study, we show that recombinant human factor H with deletions at the C-terminal end of the protein loses the ability to control the spontaneous activation of the alternative C pathway on host-like surfaces. For the pathology of HUS, the findings imply that mutations that disrupt the normal functions of the C-terminal domains prevent host polyanion recognition. The resulting uncontrolled activation of complement on susceptible host tissues appears to be the initiating event behind the acute renal failure of familial HUS patients.
This article has been cited by other articles:
|
|
 |
|
  V. P. Ferreira, A. P. Herbert, C. Cortes, K. A. McKee, B. S. Blaum, S. T. Esswein, D. Uhrin, P. N. Barlow, M. K. Pangburn, and D. Kavanagh The Binding of Factor H to a Complex of Physiological Polyanions and C3b on Cells Is Impaired in Atypical Hemolytic Uremic Syndrome J. Immunol., June 1, 2009; 182(11): 7009 - 7018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Pangburn, N. Rawal, C. Cortes, M. N. Alam, V. P. Ferreira, and M. A. L. Atkinson Polyanion-Induced Self-Association of Complement Factor H J. Immunol., January 15, 2009; 182(2): 1061 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Q. Schmidt, A. P. Herbert, D. Kavanagh, C. Gandy, C. J. Fenton, B. S. Blaum, M. Lyon, D. Uhrin, and P. N. Barlow A New Map of Glycosaminoglycan and C3b Binding Sites on Factor H J. Immunol., August 15, 2008; 181(4): 2610 - 2619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Caprioli and G. Remuzzi A mouse model of non-Shiga toxin-associated haemolytic uraemic syndrome Nephrol. Dial. Transplant., February 1, 2008; 23(2): 462 - 465. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jozsi, C. Licht, S. Strobel, S. L. H. Zipfel, H. Richter, S. Heinen, P. F. Zipfel, and C. Skerka Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency Blood, February 1, 2008; 111(3): 1512 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Ferreira and M. K. Pangburn Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes Blood, September 15, 2007; 110(6): 2190 - 2192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jozsi, S. Strobel, H.-M. Dahse, W.-s. Liu, P. F. Hoyer, M. Oppermann, C. Skerka, and P. F. Zipfel Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome Blood, September 1, 2007; 110(5): 1516 - 1518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Heinen, M. Jozsi, A. Hartmann, M. Noris, G. Remuzzi, C. Skerka, and P. F. Zipfel Hemolytic Uremic Syndrome: A Factor H Mutation (E1172Stop) Causes Defective Complement Control at the Surface of Endothelial Cells J. Am. Soc. Nephrol., February 1, 2007; 18(2): 506 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Caprioli, M. Noris, S. Brioschi, G. Pianetti, F. Castelletti, P. Bettinaglio, C. Mele, E. Bresin, L. Cassis, S. Gamba, et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Blood, August 15, 2006; 108(4): 1267 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Herbert, D. Uhrin, M. Lyon, M. K. Pangburn, and P. N. Barlow Disease-associated Sequence Variations Congregate in a Polyanion Recognition Patch on Human Factor H Revealed in Three-dimensional Structure J. Biol. Chem., June 16, 2006; 281(24): 16512 - 16520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jozsi, S. Heinen, A. Hartmann, C. W. Ostrowicz, S. Halbich, H. Richter, A. Kunert, C. Licht, R. E. Saunders, S. J. Perkins, et al. Factor H and Atypical Hemolytic Uremic Syndrome: Mutations in the C-Terminus Cause Structural Changes and Defective Recognition Functions J. Am. Soc. Nephrol., January 1, 2006; 17(1): 170 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Noris and G. Remuzzi Hemolytic Uremic Syndrome J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1035 - 1050. [Full Text] [PDF]
|
|
|
|
|
|
G. Wolf Not known from ADAM(TS-13)--novel insights into the pathophysiology of thrombotic microangiopathies Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1687 - 1693. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Caprioli, F. Castelletti, S. Bucchioni, P. Bettinaglio, E. Bresin, G. Pianetti, S. Gamba, S. Brioschi, E. Daina, G. Remuzzi, et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease Hum. Mol. Genet., December 15, 2003; 12(24): 3385 - 3395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Richards, E. J. Kemp, M. K. Liszewski, J. A. Goodship, A. K. Lampe, R. Decorte, M. H. Muslumanogglu, S. Kavukcu, G. Filler, Y. Pirson, et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome PNAS, October 28, 2003; 100(22): 12966 - 12971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H P H Neumann, M Salzmann, B Bohnert-Iwan, T Mannuelian, C Skerka, D Lenk, B U Bender, M Cybulla, P Riegler, A Konigsrainer, et al. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries J. Med. Genet., September 1, 2003; 40(9): 676 - 681. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
